Model Number CNA19 |
Device Problems
Leak/Splash (1354); Incomplete Coaptation (2507)
|
Patient Problem
Aortic Valve Insufficiency/ Regurgitation (4450)
|
Event Date 11/10/2021 |
Event Type
Injury
|
Manufacturer Narrative
|
Unknown disposition.
|
|
Event Description
|
The manufacturer were informed about the crown prt valve-size 19 leakage and regurgitation.This valve was implanted on (b)(6) 2021, after the implant of the valve the regurgitation from the leaflet closure were found by echo.Based on the echocardiography results the ejection fraction was 34% (mod 4) with impaired systolic function in septal, anteroseptal and anterior wall akinesia due to the heart failure.Hemolysis and the hematuria was reported for this patient.
|
|
Manufacturer Narrative
|
The manufacturing and material records for the crown prt aortic pericardial heart valve, model # cna19, s/n # (b)(6) , as they pertain to the reported event, were retrieved and reviewed by the manufacturer¿s quality engineering.The results confirmed that this valve satisfied all material, visual, and performance standards required for a crown prt aortic pericardial heart valve at the time of manufacture and release.A review of the function test (open/close valve) at the time of manufacture and release was also performed.The video playback showed synchronous opening and closing of the valve with smooth, continuous motion and no leaflet fluttering.Based on video playback and review for this report, the valve performed as expected and met applicable function test quality control criteria for model cna19.The manufacturer attempted to retrieve additional information on the event and treatment plan for the patient, but no further information was provided.Since the device remains implanted (no notification of valve explant was provided), no further investigation is possible at this time.Based on the available information, it is not possible to make a definitive conclusion to the reported event.However, from the document review performed, no manufacturing deficiencies were identified.The manufacturer attempted to follow up with the field, but no further information was received up to date.Should any further information be received, the manufacturer will provide a supplemental report as applicable.
|
|
Manufacturer Narrative
|
Fields updated: b4, b5, g3, g6, h2, h6.The manufacturing and material records for the crown prt aortic pericardial heart valve, model # cna19, s/n # (b)(6), as they pertain to the reported event, were retrieved and reviewed by the manufacturer¿s quality engineering.The results confirmed that this valve satisfied all material, visual, and performance standards required for a crown prt aortic pericardial heart valve at the time of manufacture and release.A review of the function test (open/close valve) at the time of manufacture and release was also performed.The video playback showed synchronous opening and closing of the valve with smooth, continuous motion and no leaflet fluttering.Based on video playback and review for this report, the valve performed as expected and met applicable function test quality control criteria for model cna19.Based on the available information, it is not possible to make a definitive conclusion to the reported event.However, from the document review performed, no manufacturing deficiencies were identified.As reported, no surgical re-intervention was performed and no more complication for the patient has been occurred.Thus, there is not enough evidence to suspect a definitive device malfunction as the device remains implanted in the patient.Thus, no further investigation is deemed warranted at this time.Should any further information be received in the future, the manufacturer will provide a supplemental report as applicable.
|
|
Event Description
|
The manufacturer were informed about the crown prt valve-size 19 leakage and regurgitation.This valve was implanted on 10 nov 2021, after the implant of the valve the regurgitation from the leaflet closure were found by echo.Based on the echocardiography results the ejection fraction was 34% (mod 4) with impaired systolic function in septal, anteroseptal and anterior wall akinesia due to the heart failure.Hemolysis and the hematuria were reported for this patient.Based on the new information received no surgical intervention were performed and no more complications has been reported from the field.
|
|
Search Alerts/Recalls
|
|